Annexon Inc (ANNX)
4.595
+0.14
(+3.26%)
USD |
NASDAQ |
Apr 25, 16:00
4.595
0.00 (0.00%)
After-Hours: 20:00
Annexon Free Cash Flow (Quarterly): -23.48M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.48M |
| September 30, 2023 | -28.31M |
| June 30, 2023 | -36.41M |
| March 31, 2023 | -33.13M |
| December 31, 2022 | -27.42M |
| September 30, 2022 | -30.89M |
| June 30, 2022 | -29.02M |
| March 31, 2022 | -35.50M |
| December 31, 2021 | -29.18M |
| September 30, 2021 | -30.48M |
| Date | Value |
|---|---|
| June 30, 2021 | -24.63M |
| March 31, 2021 | -23.47M |
| December 31, 2020 | -19.43M |
| September 30, 2020 | -13.86M |
| June 30, 2020 | -10.26M |
| March 31, 2020 | -10.00M |
| December 31, 2019 | -8.888M |
| September 30, 2019 | -7.02M |
| June 30, 2019 | -6.714M |
| March 31, 2019 | -6.003M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-36.41M
Minimum
Jun 2023
-6.714M
Maximum
Jun 2019
-22.53M
Average
-24.63M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
| Trxade Health Inc | -0.8675M |
| P3 Health Partners Inc | -15.67M |
| Arrowhead Pharmaceuticals Inc | -186.50M |
| Insmed Inc | -132.97M |
| Heron Therapeutics Inc | 2.205M |